UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Utilization of a TiO[sub.2]–CuO Bimetallic/Polyaniline Nanocomposite as a Transducer in a Solid Contact Potentiometric Sensor for the Determination of Vildagliptin

Polymers, 2023-10, Vol.15 (19)

2023

Volltextzugriff (PDF)

Neuroprotective effects of saxagliptin against radiation-induced cognitive impairment: Insights on Akt/CREB/SIRT1/BDNF signaling pathway

Toxicology and applied pharmacology, 2024-08, Vol.489, p.116994, Article 116994

2024

Volltextzugriff (PDF)

Physiologically Based Pharmacokinetic Modeling Characterizes the Drug‐Drug Interaction Between Saxagliptin and Rifampicin in Patients With Renal Impairment

Journal of clinical pharmacology, 2023-07, Vol.63 (7), p.848-858

2023

Volltextzugriff (PDF)

血液透析患者におけるサキサグリプチン投与による血糖コントロールへの影響

YAKUGAKU ZASSHI, 2020/07/01, Vol.140(7), pp.937-941

2020

Volltextzugriff (PDF)

Optimized Conditions for the Extraction of Phenolic Compounds from IAeginetia indica/I L. and Its Potential Biological Applications

Molecules (Basel, Switzerland), 2024-02, Vol.29 (5)

2024

Volltextzugriff (PDF)

Heterocycles Based on 1-adamantane

Chemistry of heterocyclic compounds (New York, N.Y. 1965), 2021-03, Vol.57 (3), p.298

2021

Volltextzugriff (PDF)

Comparative Clinical Pharmacokinetics of Dipeptidyl Peptidase-4 Inhibitors

Clinical pharmacokinetics, 2012-08, Vol.51 (8), p.501

2012

Volltextzugriff (PDF)

LC–MS/MS analysis of metformin, saxagliptin and 5‐hydroxy saxagliptin in human plasma and its pharmacokinetic study with a fixed‐dose formulation in healthy Indian subjects

Biomedical chromatography, 2017-03, Vol.31 (3), p.np-n/a

2017

Volltextzugriff (PDF)

Effect of saxagliptin as add-on therapy in patients with poorly controlled type 2 diabetes on insulin alone or insulin combined with metformin

Current medical research and opinion, 2012-04, Vol.28 (4), p.513-523

2012

Volltextzugriff (PDF)

Weak Noncovalent Interactions in Three Closely Related Adamantane-Linked 1,2,4-Triazole IN/I-Mannich Bases: Insights from Energy Frameworks, Hirshfeld Surface Analysis, IIn Silico/I 11β-HSD1 Molecular Docking and ADMET Prediction

Molecules (Basel, Switzerland), 2022-10, Vol.27 (21)

2022

Volltextzugriff (PDF)

Activation of AMPK/SIRT1/FOXO3a signaling by BMS-477118 (saxagliptin) mitigates chronic colitis in rats: uncovering new anti-inflammatory and antifibrotic roles

Frontiers in pharmacology, 2024-09, Vol.15

2024

Volltextzugriff (PDF)

Saxagliptin promotes random skin flap survival

International immunopharmacology, 2023-07, Vol.120, p.110364-110364, Article 110364

2023

Volltextzugriff (PDF)

Covalent Inhibition Mechanism of Antidiabetic DrugsVildagliptin vs Saxagliptin

ACS catalysis, 2019-03, Vol.9 (3), p.2292-2302

2019

Volltextzugriff (PDF)

Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial

Circulation (New York, N.Y.), 2014-10, Vol.130 (18), p.1579-1588

2014

Volltextzugriff (PDF)

Study of alterations in pharmacokinetics and pharmacodynamics of Saxagliptin in the presence of Rutin: An interaction study in rats

Journal of applied pharmaceutical science, 2020-11

2020

Volltextzugriff (PDF)

Saxagliptin regulates M1/M2 macrophage polarization via CaMKKβ/AMPK pathway to attenuate NAFLD

Biochemical and biophysical research communications, 2018-09, Vol.503 (3), p.1618-1624

2018

Volltextzugriff (PDF)

Design and application of molecularly imprinted electrochemical sensor for the new generation antidiabetic drug saxagliptin

Electroanalysis (New York, N.Y.), 2023-05, Vol.35 (5), p.n/a

2023

Volltextzugriff (PDF)

Different approaches for the assessment of greenness of spectrophotometric methodologies utilized for resolving the spectral overlap of newly approved binary hypoglycemic pharmaceutical mixture

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2022-05, Vol.272, p.120998, Article 120998

2022

Volltextzugriff (PDF)

Continuous Glucose Monitoring Profiles and Health Outcomes after Dapagliflozin Plus Saxagliptin vs Insulin Glargine

The journal of clinical endocrinology and metabolism, 2024-02

2024

Volltextzugriff (PDF)

Adamantane - A Lead Structure for Drugs in Clinical Practice

Current medicinal chemistry, 2016-08, Vol.23 (29), p.3245-3266

2016

Volltextzugriff (PDF)

HPTLC-densitometric analysis of selected antidiabetic drugs in presence of their degradation products

Microchemical journal, 2020-05, Vol.154, p.104560, Article 104560

2020

Volltextzugriff (PDF)

The use of SDS micelles as additive to increase fluorescence analysis of sitagliptin and saxagliptin derivatives in their tablets and human plasma

Microchemical journal, 2019-05, Vol.146, p.20-24

2019

Volltextzugriff (PDF)

Worsening Heart Failure During the Use of DPP-4 Inhibitors: Pathophysiological Mechanisms, Clinical Risks, and Potential Influence of Concomitant Antidiabetic Medications

JACC. Heart failure, 2018-06, Vol.6 (6), p.445-451

Packer, Milton

2018

Volltextzugriff (PDF)

Quantitative determination of metformin, saxagliptin and 5-hydroxy saxagliptin simultaneously by hydrophilic interaction liquid chromatography - electrospray ionization mass spectrometry and its application to a bioequivalence study with a single-pill combination in human

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2018-04, Vol.1081-1082, p.109-117

2018

Volltextzugriff (PDF)

Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review

Diabetes, obesity & metabolism, 2011, Vol.13 (1), p.7-18

Deacon, C.F

2011

Volltextzugriff (PDF)

1 – 25 von 554

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(445)
Mit Volltextzugriff
(441)

Publikationsform

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Saxagliptin
(529)
Science & Technology
(427)
Life Sciences & Biomedicine
(389)
Type 2 Diabetes
(206)
Humans
(203)
Diabetes
(178)
Sitagliptin
(170)
Adamantane - Analogs & Derivatives
(152)
Pharmacology & Pharmacy
(150)
Diabetes Mellitus, Type 2 - Drug Therapy
(142)
Diabetes Mellitus
(129)
Endocrinology & Metabolism
(123)
Male
(106)
Dipeptidyl-Peptidase Iv Inhibitors - Therapeutic Use
(100)
Alogliptin
(99)
Female
(86)
Glucose
(86)
Linagliptin
(86)
Adamantane - Therapeutic Use
(80)
Vildagliptin
(80)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Utilization of a TiO[sub.2]–CuO Bimetallic/Polyaniline Nanocomposite as a Transducer in a Solid Contact Potentiometric Sensor for the Determination of Vildagliptin

Neuroprotective effects of saxagliptin against radiation-induced cognitive impairment: Insights on Akt/CREB/SIRT1/BDNF signaling pathway

Physiologically Based Pharmacokinetic Modeling Characterizes the Drug‐Drug Interaction Between Saxagliptin and Rifampicin in Patients With Renal Impairment

血液透析患者におけるサキサグリプチン投与による血糖コントロールへの影響

Optimized Conditions for the Extraction of Phenolic Compounds from IAeginetia indica/I L. and Its Potential Biological Applications

Heterocycles Based on 1-adamantane

Comparative Clinical Pharmacokinetics of Dipeptidyl Peptidase-4 Inhibitors

LC–MS/MS analysis of metformin, saxagliptin and 5‐hydroxy saxagliptin in human plasma and its pharmacokinetic study with a fixed‐dose formulation in healthy Indian subjects

Effect of saxagliptin as add-on therapy in patients with poorly controlled type 2 diabetes on insulin alone or insulin combined with metformin

Weak Noncovalent Interactions in Three Closely Related Adamantane-Linked 1,2,4-Triazole IN/I-Mannich Bases: Insights from Energy Frameworks, Hirshfeld Surface Analysis, IIn Silico/I 11β-HSD1 Molecular Docking and ADMET Prediction

Activation of AMPK/SIRT1/FOXO3a signaling by BMS-477118 (saxagliptin) mitigates chronic colitis in rats: uncovering new anti-inflammatory and antifibrotic roles

Saxagliptin promotes random skin flap survival

Covalent Inhibition Mechanism of Antidiabetic DrugsVildagliptin vs Saxagliptin

Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial

Study of alterations in pharmacokinetics and pharmacodynamics of Saxagliptin in the presence of Rutin: An interaction study in rats

Saxagliptin regulates M1/M2 macrophage polarization via CaMKKβ/AMPK pathway to attenuate NAFLD

Design and application of molecularly imprinted electrochemical sensor for the new generation antidiabetic drug saxagliptin

Different approaches for the assessment of greenness of spectrophotometric methodologies utilized for resolving the spectral overlap of newly approved binary hypoglycemic pharmaceutical mixture

Continuous Glucose Monitoring Profiles and Health Outcomes after Dapagliflozin Plus Saxagliptin vs Insulin Glargine

Adamantane - A Lead Structure for Drugs in Clinical Practice

HPTLC-densitometric analysis of selected antidiabetic drugs in presence of their degradation products

The use of SDS micelles as additive to increase fluorescence analysis of sitagliptin and saxagliptin derivatives in their tablets and human plasma

Worsening Heart Failure During the Use of DPP-4 Inhibitors: Pathophysiological Mechanisms, Clinical Risks, and Potential Influence of Concomitant Antidiabetic Medications

Quantitative determination of metformin, saxagliptin and 5-hydroxy saxagliptin simultaneously by hydrophilic interaction liquid chromatography - electrospray ionization mass spectrometry and its application to a bioequivalence study with a single-pill combination in human

Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review

Suchergebnisse filtern